The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancer.
about
Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colonReduced expression of SIRT2 in serous ovarian carcinoma promotes cell proliferation through disinhibition of CDK4 expression.Cancer diagnostics: The journey from histomorphology to molecular profiling.Versatile ion S5XL sequencer for targeted next generation sequencing of solid tumors in a clinical laboratoryA Radiolabeled Fully Human Antibody to Human Aspartyl (Asparaginyl) β-Hydroxylase Is a Promising Agent for Imaging and Therapy of Metastatic Breast Cancer.Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1 (EFEMP1) Acts as a Potential Diagnostic Biomarker for Prostate CancerPathologists and liquid biopsies: to be or not to be?Magnetic resonance imaging tumor regression shrinkage patterns after neoadjuvant chemotherapy in patients with locally advanced breast cancer: Correlation with tumor biological subtypes and pathological response after therapy.ALK+ lung adenocarcinoma in never smokers and long-term ex-smokers: prevalence and detection by immunohistochemistry and fluorescence in situ hybridization.Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts.Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients.Spine Oncology-Metastatic Spine Tumors.Pre-clinical study of a TNFR1-targeted 18F probe for PET imaging of breast cancer.EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer.ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signaling.
P2860
Q37269345-498FB6CF-8F58-421A-AE45-6B4C7FA2BF39Q37720273-15F18424-FA78-4EB6-B585-575FD537832CQ38559476-8292A196-B75D-4EBC-BED5-A402645303DEQ38646681-70DA92F5-5FE1-4CD8-97A1-C7EF96D9BB79Q38712008-8553B823-2247-4E85-9C86-C06C8199C348Q38721452-532EED6B-1974-4424-9BFE-614689C06CE3Q38935060-4DF32D43-ABB9-43FD-917A-CA75FF7CE3A8Q40276958-737499DB-952F-40E1-A652-082C097D1604Q40513502-1F0EDDBC-F760-48CC-B63D-7DF25A35F325Q45069112-A57D0954-3C96-44E2-8646-2B936295D644Q47138018-2A5DE6E1-CEDE-4FFF-A86C-3FB693C33D6AQ47568298-2AB8930C-7379-49D6-B950-535E7B75792BQ48113710-B4DA80A6-B8AA-40BD-ABEC-658B1EAD5B62Q49861198-91F7E6F6-C371-481D-ACA6-28E80A5FD1CDQ52626866-93902EEF-775B-4AE8-A7F4-CEBECD6145F8Q52689175-5A4E5042-FCAB-46E6-BA56-11990C815518
P2860
The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The importance of molecular ma ...... ments in patients with cancer.
@en
type
label
The importance of molecular ma ...... ments in patients with cancer.
@en
prefLabel
The importance of molecular ma ...... ments in patients with cancer.
@en
P2860
P356
P1476
The importance of molecular ma ...... ments in patients with cancer.
@en
P2093
P2860
P304
P356
10.1111/JOIM.12429
P407
P577
2015-09-16T00:00:00Z